speb/financial-data huggingface dataset:
XRAY balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2102000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -434000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 434000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Minority Interest: 0.00
XRAY income_statement (quarterly, 2025-09-30) — Minority Interests: 1000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
XRAY balance_sheet (quarterly, 2025-09-30) — Net Debt: 2032000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income: -427000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -427000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -428000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -427000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -427000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -428000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -428000000.00
XRAY income_statement (quarterly, 2025-09-30) — Net Interest Income: -23000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 2000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
XRAY income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -23000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Net PPE: 972000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -3000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -857000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 95000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 95000000.00
XRAY income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 139000000.00
XRAY income_statement (quarterly, 2025-09-30) — Normalized Income: -226340000.00
XRAY cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 79000000.00
XRAY income_statement (quarterly, 2025-09-30) — Operating Income: 46000000.00
XRAY income_statement (quarterly, 2025-09-30) — Operating Revenue: 904000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 199483861.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 369000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -672000000.00
XRAY income_statement (quarterly, 2025-09-30) — Other Gand A: 355000000.00
XRAY income_statement (quarterly, 2025-09-30) — Other Income Expense: -253000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1065000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -6000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 274000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 573000000.00
XRAY income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Other Properties: 972000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Payables: 315000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1027000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
XRAY income_statement (quarterly, 2025-09-30) — Pretax Income: -230000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -7000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Raw Materials: 198000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Receivables: 654000000.00
XRAY income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 463000000.00
XRAY income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 92000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -417000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
XRAY income_statement (quarterly, 2025-09-30) — Research And Development: 37000000.00
XRAY income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 5000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1385000000.00
XRAY income_statement (quarterly, 2025-09-30) — Salaries And Wages: 3000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 9000000.00
XRAY income_statement (quarterly, 2025-09-30) — Selling General And Administration: 358000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Share Issued: 264483861.00
XRAY income_statement (quarterly, 2025-09-30) — Special Income Charges: -267000000.00
XRAY cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1478000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -857000000.00
XRAY income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -53340000.00
XRAY income_statement (quarterly, 2025-09-30) — Tax Provision: 198000000.00
XRAY income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
XRAY balance_sheet (quarterly, 2025-09-30) — Total Assets: 5653000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3495000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Debt: 2480000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1478000000.00
XRAY income_statement (quarterly, 2025-09-30) — Total Expenses: 858000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4175000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3581000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2770000000.00
XRAY income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -218000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 47000000.00
XRAY income_statement (quarterly, 2025-09-30) — Total Unusual Items: -254000000.00
XRAY income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -254000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 65000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 3106000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Work In Process: 86000000.00
XRAY balance_sheet (quarterly, 2025-09-30) — Working Capital: 667000000.00
XRAY income_statement (annual, 2025-12-31) — +Operating Expense: 1588000000.00
XRAY income_statement (quarterly, 2025-12-31) — +Operating Expense: 418000000.00
XRAY income_statement (annual, 2025-12-31) — +Total Revenue: 3680000000.00
XRAY income_statement (quarterly, 2025-12-31) — +Total Revenue: 961000000.00
XRAY balance_sheet (annual, 2025-12-31) — Accounts Payable: 300000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 300000000.00
XRAY balance_sheet (annual, 2025-12-31) — Accounts Receivable: 688000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 688000000.00
XRAY balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1572000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1572000000.00
XRAY balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6644000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6644000000.00
XRAY balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -12000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -12000000.00
XRAY cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 211000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 56000000.00
XRAY cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 211000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 56000000.00
XRAY cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 650000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 153000000.00
XRAY income_statement (annual, 2025-12-31) — Basic Average Shares: 199400000.00
XRAY income_statement (quarterly, 2025-12-31) — Basic Average Shares: 199600000.00
XRAY income_statement (annual, 2025-12-31) — Basic EPS: -3.00
XRAY income_statement (quarterly, 2025-12-31) — Basic EPS: -0.74
XRAY cash_flow (annual, 2025-12-31) — Beginning Cash Position: 272000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 363000000.00
XRAY balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 638000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 638000000.00
XRAY cash_flow (annual, 2025-12-31) — Capital Expenditure: -131000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -41000000.00
XRAY cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -131000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -41000000.00
XRAY balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 140000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 140000000.00
XRAY balance_sheet (annual, 2025-12-31) — Capital Stock: 3000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3000000.00
XRAY balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 326000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 326000000.00
XRAY balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 326000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 326000000.00
XRAY cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -128000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -32000000.00
XRAY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -80000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -99000000.00
XRAY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -132000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -45000000.00
XRAY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 235000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 101000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Account Payable: 11000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 20000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -74000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -8000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Inventory: -17000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Inventory: 44000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -7000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -7000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -5000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -32000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 13000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Payable: 11000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Payable: 20000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -63000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 12000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -7000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Receivables: -91000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Receivables: -35000000.00
XRAY cash_flow (annual, 2025-12-31) — Change In Working Capital: -222000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 29000000.00
XRAY cash_flow (annual, 2025-12-31) — Changes In Cash: 23000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Changes In Cash: -43000000.00
XRAY balance_sheet (annual, 2025-12-31) — Commercial Paper: 82000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Commercial Paper: 82000000.00
XRAY balance_sheet (annual, 2025-12-31) — Common Stock: 3000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Common Stock: 3000000.00
XRAY balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1339000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1339000000.00
XRAY cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
XRAY cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
XRAY balance_sheet (annual, 2025-12-31) — Construction In Progress: 134000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 134000000.00
XRAY income_statement (annual, 2025-12-31) — Cost Of Revenue: 1840000000.00
XRAY income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 518000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 260000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 260000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Assets: 2023000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Assets: 2023000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 47000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 47000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Debt: 313000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Debt: 313000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 360000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 360000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 74000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 74000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 74000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 74000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Liabilities: 1343000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1343000000.00
XRAY balance_sheet (annual, 2025-12-31) — Current Provisions: 118000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Current Provisions: 118000000.00
XRAY cash_flow (annual, 2025-12-31) — Deferred Income Tax: 30000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -14000000.00
XRAY cash_flow (annual, 2025-12-31) — Deferred Tax: 30000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Deferred Tax: -14000000.00
XRAY cash_flow (annual, 2025-12-31) — Depreciation: 141000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Depreciation: 37000000.00
XRAY cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 352000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 93000000.00
XRAY cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 352000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 93000000.00
XRAY income_statement (annual, 2025-12-31) — Diluted Average Shares: 199400000.00
XRAY income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 199600000.00
XRAY income_statement (annual, 2025-12-31) — Diluted EPS: -3.00
XRAY income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.74
XRAY income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -146000000.00
XRAY income_statement (annual, 2025-12-31) — EBIT: -398000000.00
XRAY income_statement (quarterly, 2025-12-31) — EBIT: -125000000.00
XRAY income_statement (annual, 2025-12-31) — EBITDA: -46000000.00
XRAY income_statement (quarterly, 2025-12-31) — EBITDA: -32000000.00
XRAY cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 31000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 6000000.00
XRAY cash_flow (annual, 2025-12-31) — End Cash Position: 326000000.00
XRAY cash_flow (quarterly, 2025-12-31) — End Cash Position: 326000000.00
XRAY cash_flow (annual, 2025-12-31) — Financing Cash Flow: -80000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -99000000.00
XRAY balance_sheet (annual, 2025-12-31) — Finished Goods: 361000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Finished Goods: 361000000.00
XRAY cash_flow (annual, 2025-12-31) — Free Cash Flow: 104000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 60000000.00
XRAY cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
XRAY income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 32000000.00
XRAY income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 19000000.00
XRAY balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -639000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -639000000.00
XRAY balance_sheet (annual, 2025-12-31) — Goodwill: 1148000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Goodwill: 1148000000.00
XRAY balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2122000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2122000000.00
XRAY balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 700000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 700000000.00
XRAY balance_sheet (annual, 2025-12-31) — Gross PPE: 2572000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2572000000.00
XRAY income_statement (annual, 2025-12-31) — Gross Profit: 1840000000.00
XRAY income_statement (quarterly, 2025-12-31) — Gross Profit: 443000000.00
XRAY income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 650000000.00
XRAY income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 153000000.00
XRAY cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 71000000.00
XRAY balance_sheet (annual, 2025-12-31) — Income Tax Payable: 30000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 30000000.00
XRAY income_statement (annual, 2025-12-31) — Interest Expense: 88000000.00
XRAY income_statement (quarterly, 2025-12-31) — Interest Expense: 22000000.00
XRAY income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 88000000.00
XRAY income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 22000000.00
XRAY cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 66000000.00
XRAY balance_sheet (annual, 2025-12-31) — Interest Payable: 44000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Interest Payable: 44000000.00
XRAY balance_sheet (annual, 2025-12-31) — Inventory: 642000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Inventory: 642000000.00
XRAY balance_sheet (annual, 2025-12-31) — Invested Capital: 3667000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3667000000.00
XRAY cash_flow (annual, 2025-12-31) — Investing Cash Flow: -132000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -45000000.00
XRAY cash_flow (annual, 2025-12-31) — Issuance Of Debt: 988000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2000000.00
XRAY balance_sheet (annual, 2025-12-31) — Land And Improvements: 52000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 52000000.00
XRAY balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 93000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 93000000.00
XRAY balance_sheet (annual, 2025-12-31) — Long Term Debt: 2015000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2015000000.00
XRAY balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2108000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2108000000.00
XRAY cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 553000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2000000.00
XRAY cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -147000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -144000000.00
XRAY balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1609000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1609000000.00
XRAY balance_sheet (annual, 2025-12-31) — Minority Interest: 1000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Minority Interest: 1000000.00
XRAY income_statement (annual, 2025-12-31) — Minority Interests: 0.00
XRAY income_statement (quarterly, 2025-12-31) — Minority Interests: -1000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
XRAY cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
XRAY balance_sheet (annual, 2025-12-31) — Net Debt: 2002000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Net Debt: 2002000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income: -146000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -146000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -145000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -146000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -146000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -598000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -145000000.00
XRAY income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -598000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -145000000.00
XRAY income_statement (annual, 2025-12-31) — Net Interest Income: -88000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Interest Income: -22000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -4000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -5000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 70000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -62000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 406000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -142000000.00
XRAY income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -88000000.00
XRAY income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -22000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -22000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -5000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 3000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 1000000.00
XRAY balance_sheet (annual, 2025-12-31) — Net PPE: 1000000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Net PPE: 1000000000.00
XRAY cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -336000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 80000000.00
XRAY balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -783000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -783000000.00
XRAY balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 94000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 94000000.00
XRAY balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 94000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 94000000.00
XRAY income_statement (annual, 2025-12-31) — Normalized EBITDA: 596000000.00
XRAY income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 108000000.00
XRAY income_statement (annual, 2025-12-31) — Normalized Income: -90820000.00
XRAY income_statement (quarterly, 2025-12-31) — Normalized Income: -7904761.90
XRAY cash_flow (annual, 2025-12-31) — Operating Cash Flow: 235000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 101000000.00
XRAY income_statement (annual, 2025-12-31) — Operating Income: 252000000.00
XRAY income_statement (quarterly, 2025-12-31) — Operating Income: 25000000.00
XRAY income_statement (annual, 2025-12-31) — Operating Revenue: 3680000000.00
XRAY income_statement (quarterly, 2025-12-31) — Operating Revenue: 961000000.00
XRAY balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 199600000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 199600000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Current Assets: 150000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 150000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 231000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 231000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 30000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 30000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -639000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -639000000.00
XRAY income_statement (annual, 2025-12-31) — Other Income Expense: -650000000.00
XRAY income_statement (quarterly, 2025-12-31) — Other Income Expense: -150000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 974000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 974000000.00
XRAY cash_flow (annual, 2025-12-31) — Other Non Cash Items: -10000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -23000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 284000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 284000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 544000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 544000000.00
XRAY income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -8000000.00
XRAY income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -10000000.00
XRAY balance_sheet (annual, 2025-12-31) — Other Properties: 139000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Other Properties: 139000000.00
XRAY balance_sheet (annual, 2025-12-31) — Payables: 330000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Payables: 330000000.00
XRAY balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 590000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 590000000.00
XRAY balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 171000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 171000000.00
XRAY balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
XRAY balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
XRAY balance_sheet (annual, 2025-12-31) — Prepaid Assets: 168000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 168000000.00
XRAY income_statement (annual, 2025-12-31) — Pretax Income: -486000000.00
XRAY income_statement (quarterly, 2025-12-31) — Pretax Income: -147000000.00
XRAY balance_sheet (annual, 2025-12-31) — Properties: 0.00
XRAY balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
XRAY cash_flow (annual, 2025-12-31) — Purchase Of Investment: -14000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -5000000.00
XRAY balance_sheet (annual, 2025-12-31) — Raw Materials: 199000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Raw Materials: 199000000.00
XRAY balance_sheet (annual, 2025-12-31) — Receivables: 737000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Receivables: 737000000.00
XRAY income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1840000000.00
XRAY income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 518000000.00
XRAY income_statement (annual, 2025-12-31) — Reconciled Depreciation: 352000000.00
XRAY income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 93000000.00
XRAY cash_flow (annual, 2025-12-31) — Repayment Of Debt: -918000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -64000000.00
XRAY cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
XRAY cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
XRAY income_statement (annual, 2025-12-31) — Research And Development: 150000000.00
XRAY income_statement (quarterly, 2025-12-31) — Research And Development: 40000000.00
XRAY income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 24000000.00
XRAY income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 6000000.00
XRAY balance_sheet (annual, 2025-12-31) — Retained Earnings: -1564000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1564000000.00
XRAY cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
XRAY cash_flow (annual, 2025-12-31) — Sale Of Investment: 10000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
XRAY income_statement (annual, 2025-12-31) — Selling General And Administration: 1438000000.00
XRAY income_statement (quarterly, 2025-12-31) — Selling General And Administration: 378000000.00
XRAY balance_sheet (annual, 2025-12-31) — Share Issued: 264500000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Share Issued: 264500000.00
XRAY cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 435000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
XRAY cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -771000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 80000000.00
XRAY income_statement (annual, 2025-12-31) — Special Income Charges: -674000000.00
XRAY income_statement (quarterly, 2025-12-31) — Special Income Charges: -159000000.00
XRAY cash_flow (annual, 2025-12-31) — Stock Based Compensation: 33000000.00
XRAY cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8000000.00
XRAY balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1339000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1339000000.00
XRAY balance_sheet (annual, 2025-12-31) — Tangible Book Value: -783000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -783000000.00
XRAY income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -134820000.00
XRAY income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1904761.90
XRAY income_statement (annual, 2025-12-31) — Tax Provision: 112000000.00
XRAY income_statement (quarterly, 2025-12-31) — Tax Provision: -2000000.00
XRAY income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
XRAY income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
XRAY balance_sheet (annual, 2025-12-31) — Taxes Receivable: 49000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 49000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Assets: 5429000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Assets: 5429000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Capitalization: 3354000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3354000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Debt: 2468000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Debt: 2468000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1340000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1340000000.00
XRAY income_statement (annual, 2025-12-31) — Total Expenses: 3428000000.00
XRAY income_statement (quarterly, 2025-12-31) — Total Expenses: 936000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4089000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4089000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3406000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3406000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2746000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2746000000.00
XRAY income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -422000000.00
XRAY income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -139000000.00
XRAY balance_sheet (annual, 2025-12-31) — Total Tax Payable: 30000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 30000000.00
XRAY income_statement (annual, 2025-12-31) — Total Unusual Items: -642000000.00
XRAY income_statement (quarterly, 2025-12-31) — Total Unusual Items: -140000000.00
XRAY income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -642000000.00
XRAY income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -140000000.00
XRAY balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 64900000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 64900000.00
XRAY balance_sheet (annual, 2025-12-31) — Treasury Stock: 3105000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 3105000000.00
XRAY balance_sheet (annual, 2025-12-31) — Work In Process: 82000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Work In Process: 82000000.00
XRAY balance_sheet (annual, 2025-12-31) — Working Capital: 680000000.00
XRAY balance_sheet (quarterly, 2025-12-31) — Working Capital: 680000000.00
XRAY income_statement (quarterly, 2026-03-31) — +Operating Expense: 397000000.00
XRAY income_statement (quarterly, 2026-03-31) — +Total Revenue: 880000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 259000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 622000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 6616000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -11000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 41000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 41000000.00
XRAY income_statement (quarterly, 2026-03-31) — Basic Average Shares: 199900000.00
XRAY income_statement (quarterly, 2026-03-31) — Basic EPS: -0.05
XRAY cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 326000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -52000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -52000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 95000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 190000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 190000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -32000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -119000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -53000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 40000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -20000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Inventory: -23000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 1000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -2000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 7000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Payable: 2000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -18000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 19000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Receivables: 60000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 44000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Changes In Cash: -132000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -32000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1318000000.00
XRAY income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 453000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 688000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Current Assets: 1845000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Current Debt: 230000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 230000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1207000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -60000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Deferred Tax: -60000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Depreciation: 38000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 79000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 79000000.00
XRAY income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 199900000.00
XRAY income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.05
XRAY income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — EBIT: -18000000.00
XRAY income_statement (quarterly, 2026-03-31) — EBITDA: 61000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -4000000.00
XRAY cash_flow (quarterly, 2026-03-31) — End Cash Position: 190000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -119000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Finished Goods: 390000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -12000000.00
XRAY income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 13000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -655000000.00
XRAY income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 353000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Goodwill: 1142000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2066000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 633000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Gross PPE: 997000000.00
XRAY income_statement (quarterly, 2026-03-31) — Gross Profit: 427000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 30000000.00
XRAY income_statement (quarterly, 2026-03-31) — Interest Expense: 24000000.00
XRAY income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 24000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 44000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Inventory: 659000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3554000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -53000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
XRAY balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 95000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2006000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2101000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -31000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1000000.00
XRAY income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
XRAY balance_sheet (quarterly, 2026-03-31) — Net Debt: 2046000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Interest Income: -24000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -7000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -82000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -31000000.00
XRAY income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -24000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -5000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 6000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Net PPE: 997000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -51000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -748000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 84000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 84000000.00
XRAY income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 115000000.00
XRAY income_statement (quarterly, 2026-03-31) — Normalized Income: 22400000.00
XRAY cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 40000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -6000000.00
XRAY income_statement (quarterly, 2026-03-31) — Operating Income: 30000000.00
XRAY income_statement (quarterly, 2026-03-31) — Operating Revenue: 880000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 200300000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 374000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -655000000.00
XRAY income_statement (quarterly, 2026-03-31) — Other Gand A: 351000000.00
XRAY income_statement (quarterly, 2026-03-31) — Other Income Expense: -48000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 924000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -15000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 321000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 518000000.00
XRAY income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Other Properties: 997000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Payables: 289000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 977000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
XRAY income_statement (quarterly, 2026-03-31) — Pretax Income: -42000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -7000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Raw Materials: 178000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Receivables: 622000000.00
XRAY income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 453000000.00
XRAY income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 79000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -82000000.00
XRAY income_statement (quarterly, 2026-03-31) — Research And Development: 44000000.00
XRAY income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 67000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1574000000.00
XRAY income_statement (quarterly, 2026-03-31) — Salaries And Wages: 2000000.00
XRAY income_statement (quarterly, 2026-03-31) — Selling General And Administration: 353000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Share Issued: 264500000.00
XRAY cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
XRAY cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -51000000.00
XRAY income_statement (quarterly, 2026-03-31) — Special Income Charges: -67000000.00
XRAY cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1318000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -748000000.00
XRAY income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -21600000.00
XRAY income_statement (quarterly, 2026-03-31) — Tax Provision: -32000000.00
XRAY income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
XRAY balance_sheet (quarterly, 2026-03-31) — Total Assets: 5229000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3324000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Debt: 2331000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1319000000.00
XRAY income_statement (quarterly, 2026-03-31) — Total Expenses: 850000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3910000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3384000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2703000000.00
XRAY income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -35000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 30000000.00
XRAY income_statement (quarterly, 2026-03-31) — Total Unusual Items: -54000000.00
XRAY income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -54000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 64200000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 3072000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Work In Process: 91000000.00
XRAY balance_sheet (quarterly, 2026-03-31) — Working Capital: 638000000.00
XRF.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 3634171.00
XRF.AX balance_sheet (annual, 2021-06-30) — Cash Equivalents: 33158.00
XRF.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: -2236556.00
XRF.AX balance_sheet (annual, 2021-06-30) — Goodwill And Other Intangible Assets: 15914665.00
XRF.AX cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -4995.00
XRF.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 858580.00